Episode
Too Good to Be True? The Promises and Risks of Compounded Peptides - Frankly Speaking Ep 484
- Published
- May 11, 2026
- Duration seconds
- 625
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/too-good-to-be-true-the-promises-and-risks-of-compounded-peptides-frankly-speaking-ep-484/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/too-good-to-be-true-the-promises-and-risks-of-compounded-peptides-frankly-speaking-ep-484.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-484 Overview: Muscle growth, tissue repair, sexual function—compounded injectable peptides are marketed online for an expanding list of uses, and they’re showing up in your patients’ medicine cabinets. Join us as we explore this growing trend, evaluate the evidence behind the claims, and discuss how to counsel patients on potential safety risks. Episode resource links: Expert Opin Drug Saf. 2026 Mar;25(3):581-588. doi: 10.1080/14740338.2025.2499670HSS J. 2025 Jul 31;21(4):15563316251355551. doi: 10.1177/15563316251355551JAMA 2017;318;(20):2004-2010. doi:10.1001/jama.2017.17069 Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected] The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.